Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length |
---|---|---|---|---|---|---|---|---|
ELMI002150 | O95644 NFATC1 NFAC1_HUMAN |
242 | 248 | HSPSTSPRASVTEESWLGAR | TP | --- | Homo sapiens (Human) | 943 |
Instance evidence
Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes |
---|---|---|---|---|---|---|---|
experimental | MI:0424 | protein kinase assay | in vivo | Sheridan,2002 | support | certain | InteractionDetection |
experimental | MI:0424 | protein kinase assay | in vitro | Sheridan,2002 | support | certain | InteractionDetection |
experimental | MI:0019 | coimmunoprecipitation | in vivo/in vitro | Sheridan,2002 | support | certain | InteractionDetection |
experimental | MI:0005 | alanine scanning | in vivo/in vitro/in silico | Sheridan,2002 | support | certain | FeatureDetection |
Pathways
KEGG: The sequence O95644 is implicated in the following 23 Pathways: (color codes: This sequence=red, interacting sequence=orange)- AGE RAGE signaling pathway in diabetic complications
- B cell receptor signaling pathway
- C type lectin receptor signaling pathway
- Cellular senescence
- Hepatitis B
- Human T cell leukemia virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Inflammatory bowel disease
- Kaposi sarcoma associated herpesvirus infection
- Lipid and atherosclerosis
- MAPK signaling pathway
- Natural killer cell mediated cytotoxicity
- Osteoclast differentiation
- Oxytocin signaling pathway
- PD L1 expression and PD 1 checkpoint pathway in cancer
- T cell receptor signaling pathway
- Th1 and Th2 cell differentiation
- Th17 cell differentiation
- Wnt signaling pathway
- Yersinia infection
- cAMP signaling pathway
- cGMP PKG signaling pathway
Please cite:
ELM-the Eukaryotic Linear Motif resource-2024 update.
(PMID:37962385)
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement